Author(s)

C. V. Krishnaswami^*, C. Ramesh, B. Sampoornam, A. Ganesan, V. Rajan

TAG VHS Diabetes Research Centre (A Unit of Voluntary Health Services Diabetes Department), Chennai, India.

Neuropathy, or nerve injury, is a severe and common impediment of diabetes. Studies evaluate that 50% of people with diabetes will develop neuropathy. Diabetic nerve injury is impairment of a single solitary nerve (also named mononeuropathy). Com- monly 2 cranial nerves Viz., cranial nerve VII and cranial nerve VI are involved in facial nerve palsies. The former one is called Bell’s palsy and is acute Lower Motor Neuron facial nerve paralysis (>80%) causing an inability to control facial muscles on the affected side. The later one is sixth nerve palsy, (the abducens nerve), which is responsible for triggering contraction of the lateral rectus muscle to abduct (i.e., turn out) the eye resulting in double vision on the affected side. In recent times, we have found to our amazement, rapid restoration of normalcy within a few hours to a few days, of Cranial Nerve palsies in diabetic subjects at our centre. We are presenting a group of cases having Type2DM over different time periods from 6 to 20 years and those who suddenly suffered facial nerve palsy and they came to VHSDRC for treatment. They were started on the new modality called the Dynamic Acupuncture Mediated Meta-physical Energy Therapy (DAMM Therapy), to recover from the facial palsy. The DAMM therapy is a unique novel way of infusing and transferring healing energy from the therapist to the patient. Within 2 - 7 sittings of DAMM therapy patients showed 75% - 100% improvement in their clinical condition.

Bell’s Palsy, Facial Palsy, Mononeuropathy, Cranial Nerve Palsy, Microangiopathy, Dynamic Acupuncture Mediated Metaphysical Energy Therapy (DAMM Therapy)

Krishnaswami, C. , Ramesh, C. , Sampoornam, B. , Ganesan, A. and Rajan, V. (2016) Metaphysical Energy Therapy in the Treatment of Cranial Nerve Palsies with Special Reference to Bell’s Palsy. Journal of Biosciences and Medicines, 4, 77-84. doi: 10.4236/jbm.2016.410008.